Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > REGULATORY
REGULATORY
- HSC’s Vaccination Policy Committee Approves Switch to 13-Valent Pediatric Pneumococcal Vaccine
June 26, 2013
- Patients Would Like to See Their Drug Costs Reduced by Half; Further Reductions in Generic Drug Prices to Become a Topic: Pharmaceutical Management Director Chikazawa
June 25, 2013
- LDP Election Platform Targets 16 Trillion Yen Healthcare Market in 2020
June 24, 2013
- 47 Products Including an AG of Allegra, but not That of Livalo, Added to NHI Price List in Latest Generic Listing
June 24, 2013
- First Generics for 5 Products Including Prograf, TS-1 Added to NHI Drug Price List
June 24, 2013
- FPMAJ May Find it Difficult to Compile Unified Statement of Views on TPP Talks Due to Disagreement among Original and Generic Drug Makers
June 24, 2013
- MHLW to Resume Inviting Requests for Development of Unapproved Drugs, Indications; No Deadline Set This Time
June 20, 2013
- MHLW to Quickly Compile Studies on Reported HPV Vaccine Adverse Events, Give Clear Explanation to Public: Minister Tamura
June 20, 2013
- Top Priorities for Next Midterm Plan to Include Greater Sophistication in Review and Consultation: PMDA
June 20, 2013
- MHLW to Temporarily Withdraw Recommendation of Preventive Cervical Cancer Vaccinations
June 18, 2013
- PMDA Building “Database on Unapproved Drugs” to Accelerate Elimination of Drug Lag
June 18, 2013
- Cabinet Approves PM Abe’s Growth Strategy, Regulatory Reform Plan
June 17, 2013
- Council to Discuss Problem of Prolonged Delivery Price Negotiations at Meeting on June 27
June 17, 2013
- Pharmaceutical Affairs Council Approves Revised Draft Plan to Reduce Manufacturing Costs of Blood Products
June 17, 2013
- CSIMC’s Expert Subcommittee on NHI Drug Pricing Affairs to Hold Hearings for Drug Pricing Organization at Next Meeting in July
June 14, 2013
- CSIMC Approves Plans for FY2013 Market Price Survey of Similar Size as 2 Years Ago
June 14, 2013
- CSIMC Expert Subcommittee: Reps Agree on Need to Redress Price Variations of Generics
June 13, 2013
- Japan’s Target Drug Market Size Revised Up to 12.8 Trillion Yen in 2020: Growth Strategy
June 13, 2013
- Reprocessing of Expired Anti-Influenza Drugs to Be Considered “If Necessary”
June 13, 2013
- Only About 50% of Doctors Aware of ADR Relief System: PMDA
June 12, 2013
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…